Sheng-Han Kuo, MD
- Assistant Professor of Neurology
Dr. Kuo is a Movement Disorders specialist caring for patients with ataxia, Parkinson's disease, and tremor. He also sees patients with dystonia, Tourette's syndrome, myoclonus, and chorea. His primary clinical interest is ataxia, including hereditary ataxias, neurodegenerative ataxias, and acquired causes of ataxia.
Dr. Kuo is a physician-scientist focusing on research of cerebellar diseases and Parkinson's disease. He has investigated the cerebellar changes in the post-mortem tissues of patients with essential tremor, and is involved in the natural history study and clinical trials of spinocerebellar ataxias. He has published articles in Neurology, Movement Disorders, and the Journal of Neuroscience. Dr. Kuo is a recipient of the American Academy of Neurology Research Fellowship Award and the Parkinson's Disease Foundation Lucien Côté Early Investigator Award in Clinical Genetics.
For more information, please visit Dr. Kuo's Laboratory website.
Departmental Appointments
- Department of Neurology
Division of Movement Disorders
Board Certifications
- Neurology
Areas of Expertise
- Ataxia
- Tremor
- Movement Disorders
- Parkinson's Disease
- Dystonia
- Tourette's Syndrome
Languages Spoken
(in addition to English)
- Chinese
Education & Training
- National Taiwan University School of Medicine (Taiwan)
- Internship: Baylor College of Medicine
- Residency: Baylor College of Medicine
Locations
Neurological Institute of New York
710 West 168th Street
New York, NY 10032- For new and current patient appointments, call:
- (212) 305-1303
Provider Affiliations
- NewYork-Presbyterian/Columbia
Insurance Programs
Please contact the provider's office directly to verify that your particular insurance is accepted.
- Aetna [EPO, HMO, Medicare Managed Care, NY Signature, POS, PPO, Signature Administrators, Student Health]
- Affinity [Essential Plan, Medicaid Managed Care, Medicare Managed Care]
- Amida Care [Special Needs Plan]
- Cigna [EPO, Great West, HMO, POS, PPO]
- Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]
- Empire Blue Cross Blue Shield [Blue Priority, EPO, HMO, Medicare (Mediblue), NYP Employee Plan, Pathway (Exchange), POS, PPO]
- Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]
- Fidelis Care [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]
- Healthfirst [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]
- Local 1199 [Local 1199]
- MagnaCare [MagnaCare]
- Multiplan [Multiplan]
- Oxford Health Plans [Freedom, Liberty, Medicare Managed Care]
- UnitedHealthcare [Columbia University Employee Plan, EPO, Essential Plan, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]
- VNSNY CHOICE [Medicare Managed Care, SelectHealth]
- WellCare [Medicaid Managed Care, Medicare Managed Care]
This provider accepts new patients
Appointment Phone Number: (212) 305-1303
Links
Committees/Societies/Memberships
Clinical Research Consortium for Spinocerebellar Ataxias (CRC-SCA)
Tremor Research Group
American Academy of Neurology
Movement Disorders Society
Honors & Awards
Parkinson’s Disease Foundation Lucien Côté Early Investigator Award in Clinical Genetics
Louis V. Gerstner Jr. Scholar Award
American Academy of Neurology Research Fellowship
NIH Grants
CEREBELLAR CIRCUITRY IN THE PATHOPHYSIOLOGY OF TREMOR (Federal Gov)
Sep 5 2018 - Jun 30 2023
A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CX-8998 FOR ESSENTIAL TREMOR (P&S Industry Clinical Trial)
Dec 4 2017 - Dec 4 2022
ABERRANT SYNAPTIC ORGANIZATION IN TREMOR DISORDERS (Private)
Jun 1 2018 - May 31 2020
PATHOLOGOMICS: ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATION (Federal Gov)
Feb 1 2015 - Jan 31 2020
A PRECLINICAL STUDY OF THE EFFECTIVENESS OF D-AMINO ACID OXIDASE INHIBITOR IN ESSENTIAL TREMOR (Private)
Oct 30 2018 - Oct 29 2019
OPTOGENETIC INTERROGATION OF CEREBELLAR CIRCUITRY OF A NOVEL MOUSE MODEL OF ESSENTIAL TREMOR (Private)
Jul 1 2018 - Jun 30 2019
CLINICAL RESEARCH CONSORTIUM FOR THE STUDY OF CEREBELLAR ATAXIAS (Private)
Apr 1 2018 - Mar 31 2019
EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS (Federal Gov)
Jan 1 2018 - Dec 31 2018
A MODEL SYSTEM FOR STUDYING THE INTERACTION OF MULTIPLE PROCESSES FOR MOTOR LEARNING (Federal Gov)
Sep 1 2013 - Aug 31 2018
THE ROLE OF GLUCOCEREBROSIDASE AND CHAPERONE-MEDIATED AUTOPHAGY IN PARKINSON S DISEASE (Federal Gov)
Jul 1 2013 - Jun 30 2018
CLINICAL RESEARCH CONSORTIUM FOR THE STUDY OF (Private)
Jan 1 2017 - Dec 31 2017
PARKINSON S DISEASE FOUNDATION (PDF) RESEARCH CENTER GRANT (Private)
Jul 1 2016 - Jun 30 2017
VALIDATION OF CHAPERONE-MEDIATED AUTOPHAGY DYSFUNCTION AND GBA ACTIVITY IN GENETIC PD IPSC-DERIVED MDA NEURONS (Private)
Feb 26 2016 - Apr 25 2017
ABNORMAL CLIMBING FIBER - PURKINJE CELL SYNAPSES IN ESSENTIAL TREMOR (Private)
Jul 1 2015 - Jun 30 2016
PARKINSONS DISEASE FOUNDATION RESEARCH CENTER GRANT (Private)
Jul 1 2000 - Jun 30 2016
MECHANISMS OF SUBSTANTIA NIGRA NEURONAL DEATH IN PARKINSON S DISEASE (Private)
Sep 1 2012 - Aug 31 2015
THE ROLE OF EXCLOTOXICITY IN ESSENTIAL TREMOR CEREBELLUM (Private)
Jul 1 2014 - Jun 30 2015
PARKINSONS DISEASE FOUNDATION RESEARCH CENTER GRANT (Private)
Jul 1 2000 - Jun 30 2015
THE ROLE OF GLUCOCEREBROSIDASE AND CHAPERONE-MEDIATED AUTOPHAGY IN PARKINSON S DISEASE (Private)
Sep 1 2013 - Aug 31 2014
MECHANISMS OF DOPAMINE NEURON DEGENERATION (Federal Gov)
Aug 1 2000 - Jul 31 2014
PARKINSON S DISEASE FOUNDATION RESEARCH CENTE (Private)
Jul 1 2000 - Jun 30 2014
PARKINSON S DISEASE FOUNDATION RESEARCH CENTE (Private)
Jul 1 2000 - Jun 30 2014
GLUCOCEREBROSIDASE AND MITOCHONDRIAL AUTOPHAGY IN DOPAMINERGIC NEURONS (Private)
Jul 1 2011 - Sep 30 2013
MUTANT GLUCOCEREBROSIDASE CAUSES DYSFUNCTIONAL CHAPERONE MEDIATED AUTOPHAGY AND ALPHA-SYNUCLEIN ACCUMULATION IN PATIENT FIBROBLAST- DERIVED DOPAMINERGIC NEURONS (Private)
Jun 30 2012 - Aug 31 2013
PARKINSON"S DISEASE FOUNDATION RESEARCH CENTER GRANT CLINICA L CORE (Private)
Jul 1 2000 - Jun 30 2013
